Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 …
EA Christofides, O Puente, P Norwood… - Diabetes, Obesity …, 2024 - Wiley Online Library
Aim To evaluate the equivalence of immunogenicity, safety and efficacy of Gan & Lee (GL)
Glargine (Basalin®; Gan & Lee Pharmaceutical) with that of the reference product (Lantus®) …
Glargine (Basalin®; Gan & Lee Pharmaceutical) with that of the reference product (Lantus®) …
Efficacy and safety of insulin degludec/insulin aspart compared with a conventional premixed insulin or basal insulin: a meta-analysis
S Moon, HS Chung, YJ Kim, JM Yu, WJ Jeong, J Park… - Metabolites, 2021 - mdpi.com
Insulin degludec/insulin aspart (IDegAsp) is a novel co-formulation of 70% insulin degludec
and 30% insulin aspart. The present meta-analysis was conducted to assess the efficacy …
and 30% insulin aspart. The present meta-analysis was conducted to assess the efficacy …
[HTML][HTML] Efficacy, safety and treatment satisfaction of transition to a regimen of insulin degludec/aspart: A pilot study
N Yang, L Lv, SM Han, LY He, ZY Li, YC Yang… - World Journal of …, 2025 - wjgnet.com
BACKGROUND There is a lack of clinical evidence on the efficacy and safety of transitioning
from a thrice-daily pre-mixed insulin or basal-prandial regimen to insulin deglu-dec/aspart …
from a thrice-daily pre-mixed insulin or basal-prandial regimen to insulin deglu-dec/aspart …
Insulin glargine in critically ill patients: once/day versus twice/day dosing
MA Fox, MC Perry, X Liu‐DeRyke - … : The Journal of Human …, 2020 - Wiley Online Library
Objective Twice/day dosing of insulin glargine has been used to treat hyperglycemia in
clinical practice; however, data supporting its use in the critically ill population are lacking …
clinical practice; however, data supporting its use in the critically ill population are lacking …
Retrospective Analysis of Once-Daily Versus Twice-Daily Insulin Glargine Dosing in Noncritically Ill Individuals
D Hogue, J Clements, A Wright - Diabetes Spectrum, 2024 - Am Diabetes Assoc
Background Insulin is the treatment of choice for diabetes care in the hospital. There is some
debate regarding the efficacy and safety of once-daily versus twice-daily insulin glargine in …
debate regarding the efficacy and safety of once-daily versus twice-daily insulin glargine in …
Detection of recombinant Pichia pastoris producing glargine
The global prevalence of diabetes continues to rise. Diabetes management involves the
administration of insulin to help regulate blood glucose levels. Currently, two main types of …
administration of insulin to help regulate blood glucose levels. Currently, two main types of …
Insulin Glargine
IPS Alert - publications.aap.org
The Institute for Safe Medication Practices (ISMP) National Medication Errors Reporting
Program (MERP) has issued a safety alert regarding reports of patients incorrectly using …
Program (MERP) has issued a safety alert regarding reports of patients incorrectly using …